POST DETAILS

Post No: 632974 May 21, 2016, 03:45PM
Guest wrote:

PTCT May 20th
over $9 per share in cash and still trading at only $8.
Plus real sales
beat q1 top and bottom line
150% sales increase q1 yoy
recent Europe approval of MD Translarma
FDA beatdown was administration on the application not the drug tests
Potential buyout (Sanofi from Feb see articles)


This baby is going up from here...

Type the characters that you see in the box (5 characters).